Literature DB >> 35705310

Inter-rater variability in scoring of Addenbrooke's Cognitive Examination-Third Edition (ACE-III) protocols.

Miranda J Say1,2, Ciarán O'Driscoll3.   

Abstract

BACKGROUND: Despite its wide use in dementia diagnosis on the basis of cut-off points, the inter-rater variability of the Addenbrooke's Cognitive Examination-Third Edition (ACE-III) has been poorly studied.
METHODS: Thirty-one healthcare professionals from an older adults' mental health team scored two ACE-III protocols based on mock patients in a computerised form. Scoring accuracy, as well as total and domain-specific scoring variability, were calculated; factors relevant to participants were obtained, including their level of experience and self-rated confidence administering the ACE-III.
RESULTS: There was considerable inter-rater variability (up to 18 points for one of the cases), and one case's mean score was significantly higher (by nearly four points) than the true score. The Fluency, Visuospatial and Attention domains had greater levels of variability than Language and Memory. Higher scoring accuracy was not associated with either greater levels of experience or higher self-confidence in administering the ACE-III.
CONCLUSIONS: The results suggest that the ACE-III is susceptible to scoring error and considerable inter-rater variability, which highlights the critical importance of initial, and continued, administration and scoring training.

Entities:  

Keywords:  ACE-III; dementia; inter-rater variability; scoring

Year:  2022        PMID: 35705310     DOI: 10.1080/23279095.2022.2083964

Source DB:  PubMed          Journal:  Appl Neuropsychol Adult        ISSN: 2327-9095            Impact factor:   2.248


  1 in total

1.  The Influence of Interpersonal Trust on Rural Residents' Willingness to Participate in Mutual Aid for the Aged: An Empirical Analysis Based on the Survey Data of Hubei and Henan Provinces.

Authors:  Beibei Liu; Yongyong Sun
Journal:  Comput Intell Neurosci       Date:  2022-08-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.